Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: ADVANCED ACCELERATOR APPLICATIONS USA INC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2023-09-30 to 2023-12-29
Current total value of award: $468068.42
Description: NUCLEAR MEDICINE FDA APPROVED LUTATHERA.